Efficacy and Safety of Nitrazine in the Treatment of ALS

NCT04950647 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Nitrofurazone Group 1
DRUG: Nitroketazine Group 2
DRUG: placebo group

Sponsor

Peking University Third Hospital

Collaborators

[object Object]